The One in a Million Podcast
from Novartis Canada Medical Affairs
Artificial intelligence & machine learning for rare diseases – A conversation with Prof. Ian Stedman
You last listened June 23, 2021
Do artificial intelligence and machine learning have the potential to change the way rare diseases are diagnosed? What are the ethical considerations related to these technologies? In this episode, Prof. Ian Stedman discusses the different applications of AI in the healthcare system and how new technologies may support the identification of rare diseases and the use of precision medicine in the future.
Our host, Dr. Michelle Batthish (Associate Professor in the Department of Pediatrics' Division of Rheumatology at McMaster University) invites you to listen into the first episode of the first series of the One in a Million Podcast, which will serve as a background and introduction into the world of autoinflammation.
Ian Stedman is an Assistant Professor, Canadian Public Law and Governance in the School of Public Policy and Administration. He is also cross-appointed to the graduate program at Osgoode Hall Law School. Being a person with a rare disease, Professor Stedman also advocates for the rare disease community and has a growing research program focusing on the technologies and policies driving greater personalization in healthcare. He currently sits as a member of the CIHR Institute of Genetics' Institute Advisory Board and previously held the inaugural research fellowship in Artificial Intelligence Law & Ethics at Toronto’s Hospital for Sick Children’s Centre for Computational Medicine.